These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy. Peterson DE, Barker NP, Akhmadullina LI, Rodionova I, Sherman NZ, Davidenko IS, Rakovskaya GN, Gotovkin EA, Shinkarev SA, Kopp MV, Kulikov EP, Moiseyenko VM, Gertner JM, Firsov I, Tuleneva T, Yarosh A, Woon CW. J Clin Oncol; 2009 Sep 10; 27(26):4333-8. PubMed ID: 19636011 [Abstract] [Full Text] [Related]
8. The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test. Choi K, Lee SS, Oh SJ, Lim SY, Lim SY, Jeon WK, Oh TY, Kim JW. Clin Nutr; 2007 Feb 10; 26(1):57-62. PubMed ID: 16949180 [Abstract] [Full Text] [Related]
9. [High incidence-rate of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy (FEC100)]. Fukazawa M, Kawaguchi H, Shigematsu H, Koga C, Mori E, Nishimura S, Nakamura Y, Satou S, Sawamura K, Kashiwaba K, Ohno S. Gan To Kagaku Ryoho; 2012 Mar 10; 39(3):395-8. PubMed ID: 22421766 [Abstract] [Full Text] [Related]
11. Double-blinded, placebo-controlled trial on intravenous L-alanyl-L-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer. Cerchietti LC, Navigante AH, Lutteral MA, Castro MA, Kirchuk R, Bonomi M, Cabalar ME, Roth B, Negretti G, Sheinker B, Uchima P. Int J Radiat Oncol Biol Phys; 2006 Aug 01; 65(5):1330-7. PubMed ID: 16765532 [Abstract] [Full Text] [Related]
12. Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial. Wu HG, Song SY, Kim YS, Oh YT, Lee CG, Keum KC, Ahn YC, Lee SW. Cancer; 2009 Aug 15; 115(16):3699-708. PubMed ID: 19514089 [Abstract] [Full Text] [Related]
18. Effects of a Plantago ovata-based herbal compound in prevention and treatment of oral mucositis in patients with breast cancer receiving chemotherapy: A double-blind, randomized, controlled crossover trial. Hasheminasab FS, Hashemi SM, Dehghan A, Sharififar F, Setayesh M, Sasanpour P, Tasbandi M, Raeiszadeh M. J Integr Med; 2020 May 15; 18(3):214-221. PubMed ID: 32268991 [Abstract] [Full Text] [Related]